Want to keep yourself up to date with the latest news from Bkoffman?
Subscribe using the "Follow" button below and we provide you with customized updates, via topic or tag, that get delivered to your email address, your smartphone or on your dedicated news page on follow.it.
You can unsubscribe at any time painlessly.
Title of Bkoffman: "Learning from and about cancer (chronic lymphocytic leukemia or CLL) by Dr. Brian Koffman"
Is this your feed? Claim it!
Until recently researching CLL was a dead end in a hematologist’s career, but Dr. Binet and Dr. Kanti Rai changed that with their staging of CLL.
Their staging began to organizing thinking around CLL and helps sort out the wide heterogeneity or differences seen i...
As I said before, August 2025 marks two full years that I’ve enjoyed the benefits from my trial of epcoritamab, a bispecific T -cell engaging monoclonal antibody for my CLL. But the last remains of my chronic lymphocytic leukemia (CLL) have remained stubbornly persistent for about a year and half. I have been in a complete remission (CR) with normal blood counts, normal physi...